Clinical Trial Update: "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a deuterated psilocin analog (CYB003) in adults with major depressive disorder is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• CYB003 (deuterated psilocin analog)

Snippet

Sponsor: Cybin IRL Limited | Conditions: Major Depressive Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING